TreeWAS – Variant ID: rs1987778

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I69 Sequelae of cerebrovascular disease	0.000	0.269	0.731
I69.3 Sequelae of cerebral infarction	0.000	0.270	0.730
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.274	0.726
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.311	0.689
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.349	0.650
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.518	0.482
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.556	0.444
I63.9 Cerebral infarction, unspecified	0.000	0.686	0.314
I63 Cerebral infarction	0.000	0.728	0.272
I60-I69 Cerebrovascular diseases	0.000	0.733	0.267
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.000	0.793	0.207
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.000	0.794	0.206
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.000	0.796	0.204
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.000	0.798	0.202
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.000	0.799	0.201
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.000	0.804	0.195
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.000	0.804	0.195
I61 Intracerebral haemorrhage	0.000	0.811	0.189
I68 Cerebrovascular disorders in diseases classified elsewhere	0.000	0.813	0.187
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.000	0.830	0.170
I61.9 Intracerebral haemorrhage, unspecified	0.000	0.832	0.168
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries	0.000	0.837	0.163
I61.3 Intracerebral haemorrhage in brain stem	0.000	0.838	0.162
I66.9 Occlusion and stenosis of unspecified cerebral artery	0.000	0.843	0.157
I66.3 Occlusion and stenosis of cerebellar arteries	0.000	0.850	0.150
I61.5 Intracerebral haemorrhage, intraventricular	0.000	0.853	0.147
I66.8 Occlusion and stenosis of other cerebral artery	0.000	0.853	0.146
I66.2 Occlusion and stenosis of posterior cerebral artery	0.000	0.853	0.146
I66.1 Occlusion and stenosis of anterior cerebral artery	0.000	0.853	0.146
G81.9 Hemiplegia, unspecified	0.000	0.860	0.140
I68.8 Other cerebrovascular disorders in diseases classified elsewhere	0.000	0.866	0.134
I68.2 Cerebral arteritis in other diseases classified elsewhere	0.000	0.866	0.134
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere	0.000	0.866	0.134
I65.1 Occlusion and stenosis of basilar artery	0.000	0.867	0.132
I68.0 Cerebral amyloid angiopathy	0.000	0.870	0.130
I61.4 Intracerebral haemorrhage in cerebellum	0.000	0.875	0.125
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.000	0.877	0.123
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.000	0.878	0.122
I66.0 Occlusion and stenosis of middle cerebral artery	0.000	0.878	0.121
I65.0 Occlusion and stenosis of vertebral artery	0.000	0.879	0.121
I61.6 Intracerebral haemorrhage, multiple localised	0.000	0.880	0.119
I61.8 Other intracerebral haemorrhage	0.000	0.882	0.118
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.000	0.884	0.116
I65.8 Occlusion and stenosis of other precerebral artery	0.000	0.885	0.115
I60 Subarachnoid haemorrhage	0.000	0.888	0.112
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.000	0.890	0.109
I65.2 Occlusion and stenosis of carotid artery	0.000	0.891	0.109
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.000	0.899	0.101
I63.8 Other cerebral infarction	0.000	0.901	0.099
I60.4 Subarachnoid haemorrhage from basilar artery	0.000	0.907	0.093
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.000	0.910	0.090
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.000	0.911	0.089
I62 Other nontraumatic intracranial haemorrhage	0.000	0.911	0.089
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.000	0.915	0.085
I60.5 Subarachnoid haemorrhage from vertebral artery	0.000	0.919	0.080
G81 Hemiplegia	0.000	0.933	0.067
I62.1 Nontraumatic extradural haemorrhage	0.000	0.934	0.065
I60.9 Subarachnoid haemorrhage, unspecified	0.000	0.942	0.058
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.000	0.945	0.055
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.000	0.945	0.055
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.000	0.951	0.049
G81.0 Flaccid hemiplegia	0.000	0.952	0.048
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.001	0.957	0.042
G81.1 Spastic hemiplegia	0.000	0.962	0.038
I60.8 Other subarachnoid haemorrhage	0.001	0.964	0.035
I67 Other cerebrovascular diseases	0.000	0.965	0.035
G80-G83 Cerebral palsy and other paralytic syndromes	0.000	0.968	0.032
G80 Infantile cerebral palsy	0.000	0.972	0.028
G83 Other paralytic syndromes	0.000	0.974	0.026
I67.0 Dissection of cerebral arteries, nonruptured	0.000	0.974	0.026
I67.7 Cerebral arteritis, not elsewhere classified	0.000	0.974	0.026
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.001	0.974	0.024
I67.5 Moyamoya disease	0.000	0.974	0.026
I67.3 Progressive vascular leukoencephalopathy	0.000	0.974	0.026
I67.4 Hypertensive encephalopathy	0.000	0.975	0.025
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.000	0.976	0.024
G80.9 Infantile cerebral palsy, unspecified	0.000	0.976	0.024
G83.1 Monoplegia of lower limb	0.000	0.977	0.023
G83.8 Other specified paralytic syndromes	0.000	0.978	0.022
G80.8 Other infantile cerebral palsy	0.000	0.978	0.022
G80.2 Infantile hemiplegia	0.000	0.979	0.021
G80.1 Spastic diplegia	0.000	0.979	0.021
I64 Stroke, not specified as haemorrhage or infarction	0.000	0.979	0.021
G80.0 Spastic cerebral palsy	0.000	0.979	0.021
G80.4 Ataxic cerebral palsy	0.000	0.979	0.021
G80.3 Dyskinetic cerebral palsy	0.000	0.979	0.021
I67.2 Cerebral atherosclerosis	0.000	0.980	0.020
G83.3 Monoplegia, unspecified	0.000	0.980	0.020
G83.2 Monoplegia of upper limb	0.000	0.980	0.019
G83.5 Locked-in syndrome	0.000	0.981	0.019
G83.0 Diplegia of upper limbs	0.000	0.981	0.019
I67.9 Cerebrovascular disease, unspecified	0.000	0.981	0.019
I67.1 Cerebral aneurysm, nonruptured	0.000	0.982	0.018
J93.1 Other spontaneous pneumothorax	0.000	0.982	0.018
J93.9 Pneumothorax, unspecified	0.000	0.982	0.018
J93 Pneumothorax	0.000	0.983	0.017
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.001	0.983	0.016
G83.9 Paralytic syndrome, unspecified	0.000	0.984	0.016
J93.0 Spontaneous tension pneumothorax	0.000	0.984	0.016
G83.4 Cauda equina syndrome	0.000	0.985	0.015
Z99.2 Dependence on renal dialysis	0.000	0.985	0.015
Z99.3 Dependence on wheelchair	0.000	0.986	0.014
Z99 Dependence on enabling machines and devices, not elsewhere classified	0.000	0.987	0.013
T43.5 Other and unspecified antipsychotics and neuroleptics	0.013	0.987	0.000
G82 Paraplegia and tetraplegia	0.000	0.989	0.011
J92.9 Pleural plaque without asbestos	0.000	0.989	0.011
J92 Pleural plaque	0.000	0.989	0.011
K59.1 Functional diarrhoea	0.000	0.989	0.011
Z99.9 Dependence on unspecified enabling machine and device	0.000	0.989	0.011
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.011	0.989	0.000
J92.0 Pleural plaque with presence of asbestos	0.000	0.990	0.010
J90-J94 Other diseases of pleura	0.000	0.990	0.010
Z99.8 Dependence on other enabling machines and devices	0.000	0.990	0.010
T43.2 Other and unspecified antidepressants	0.010	0.990	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
Z99.4 Dependence on artificial heart	0.000	0.990	0.009
R29.6 Tendency to fall, not elsewhere classified	0.000	0.991	0.009
Z99.0 Dependence on aspirator	0.000	0.991	0.009
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.009	0.991	0.000
T36 Poisoning by systemic antibiotics	0.009	0.991	0.000
J94 Other pleural conditions	0.000	0.991	0.009
T36.0 Penicillins	0.009	0.991	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.009	0.991	0.000
J93.8 Other pneumothorax	0.000	0.991	0.008
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.008	0.991	0.000
G82.3 Flaccid tetraplegia	0.000	0.992	0.008
G82.0 Flaccid paraplegia	0.000	0.992	0.008
J94.2 Haemothorax	0.000	0.992	0.008
T43.3 Phenothiazine antipsychotics and neuroleptics	0.008	0.992	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.008	0.992	0.000
T43.6 Psychostimulants with abuse potential	0.008	0.992	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.008	0.992	0.000
Z49.0 Preparatory care for dialysis	0.000	0.992	0.008
T43.9 Psychotropic drug, unspecified	0.008	0.992	0.000
L30.8 Other specified dermatitis	0.000	0.992	0.008
G82.2 Paraplegia, unspecified	0.000	0.993	0.007
Z99.1 Dependence on respirator	0.000	0.993	0.007
D47.4 Osteomyelofibrosis	0.007	0.993	0.000
G82.1 Spastic paraplegia	0.000	0.993	0.007
T36.4 Tetracyclines	0.007	0.993	0.000
J94.8 Other specified pleural conditions	0.000	0.993	0.007
T36.3 Macrolides	0.007	0.993	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.007	0.993	0.000
T36.8 Other systemic antibiotics	0.007	0.993	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.007	0.993	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.007	0.993	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.007	0.993	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.007	0.993	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.007	0.993	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.007	0.993	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.007	0.993	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.007	0.993	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.007	0.993	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.007	0.993	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.007	0.993	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.007	0.993	0.000
T44.0 Anticholinesterase agents	0.007	0.993	0.000
H00.0 Hordeolum and other deep inflammation of eyelid	0.007	0.993	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.007	0.993	0.000
T38.0 Glucocorticoids and synthetic analogues	0.007	0.993	0.000
T36.9 Systemic antibiotic, unspecified	0.007	0.993	0.000
T36.7 Antifungal antibiotics, systemically used	0.007	0.993	0.000
T36.6 Rifamycins	0.007	0.993	0.000
T36.5 Aminoglycosides	0.007	0.993	0.000
T36.2 Chloramphenicol group	0.007	0.993	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.007	0.993	0.000
G82.5 Tetraplegia, unspecified	0.000	0.993	0.006
J94.0 Chylous effusion	0.000	0.993	0.006
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.006	0.993	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.006	0.994	0.000
F20.9 Schizophrenia, unspecified	0.006	0.994	0.000
J94.9 Pleural condition, unspecified	0.000	0.994	0.006
T38.8 Other and unspecified hormones and their synthetic substitutes	0.006	0.994	0.000
T38.1 Thyroid hormones and substitutes	0.006	0.994	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.006	0.994	0.000
G82.4 Spastic tetraplegia	0.000	0.994	0.006
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.006	0.994	0.000
T38.9 Other and unspecified hormone antagonists	0.006	0.994	0.000
T38.7 Androgens and anabolic congeners	0.006	0.994	0.000
T38.5 Other oestrogens and progestogens	0.006	0.994	0.000
T38.4 Oral contraceptives	0.006	0.994	0.000
T38.2 Antithyroid drugs	0.006	0.994	0.000
T47.0 Histamine H(2)-receptor antagonists	0.006	0.994	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.006	0.994	0.000
J94.1 Fibrothorax	0.000	0.994	0.006
K81.9 Cholecystitis, unspecified	0.000	0.994	0.006
T45.0 Antiallergic and antiemetic drugs	0.006	0.994	0.000
R29 Other symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.994	0.006
T45.5 Anticoagulants	0.006	0.994	0.000
M79.86 Other specified soft tissue disorders (Lower leg)	0.000	0.994	0.006
T47.2 Stimulant laxatives	0.005	0.994	0.000
T45.4 Iron and its compounds	0.005	0.995	0.000
F20 Schizophrenia	0.005	0.995	0.000
K43.0 Ventral hernia with obstruction, without gangrene	0.000	0.995	0.005
F20.5 Residual schizophrenia	0.005	0.995	0.000
T42.1 Iminostilbenes	0.005	0.995	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.005	0.995	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.005	0.995	0.000
T48.4 Expectorants	0.005	0.995	0.000
T48.3 Antitussives	0.005	0.995	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.005	0.995	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.005	0.995	0.000
T48.0 Oxytocic drugs	0.005	0.995	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.005	0.995	0.000
T45.8 Other primarily systemic and haematological agents	0.005	0.995	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.995	0.000
T45.6 Fibrinolysis-affecting drugs	0.005	0.995	0.000
T45.3 Enzymes, not elsewhere classified	0.005	0.995	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.005	0.995	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
T47.7 Emetics	0.005	0.995	0.000
T47.5 Digestants	0.005	0.995	0.000
T47.3 Saline and osmotic laxatives	0.005	0.995	0.000
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.995	0.005
T47.4 Other laxatives	0.005	0.995	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.005	0.995	0.000
T48.5 Anti-common-cold drugs	0.005	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.005	0.995	0.000
T37.5 Antiviral drugs	0.005	0.995	0.000
T37.4 Anthelminthics	0.005	0.995	0.000
T37.3 Other antiprotozoal drugs	0.005	0.995	0.000
T37.1 Antimycobacterial drugs	0.005	0.995	0.000
T37.0 Sulphonamides	0.005	0.995	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.005	0.995	0.000
T41.5 Therapeutic gases	0.005	0.995	0.000
T41.4 Anaesthetic, unspecified	0.005	0.995	0.000
T41.3 Local anaesthetics	0.005	0.995	0.000
T41.2 Other and unspecified general anaesthetics	0.005	0.995	0.000
T41.1 Intravenous anaesthetics	0.005	0.995	0.000
T41.0 Inhaled anaesthetics	0.005	0.995	0.000
T47.6 Antidiarrhoeal drugs	0.005	0.995	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.005	0.995	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
F20.0 Paranoid schizophrenia	0.005	0.995	0.000
T45.2 Vitamins, not elsewhere classified	0.005	0.995	0.000
T49.9 Topical agent, unspecified	0.005	0.995	0.000
T49.8 Other topical agents	0.005	0.995	0.000
T49.7 Dental drugs, topically applied	0.005	0.995	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.005	0.995	0.000
T49.5 Ophthalmological drugs and preparations	0.005	0.995	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.005	0.995	0.000
T49.3 Emollients, demulcents and protectants	0.005	0.995	0.000
T49.2 Local astringents and local detergents	0.005	0.995	0.000
T49.1 Antipruritics	0.005	0.995	0.000
D22.4 Melanocytic naevi of scalp and neck	0.005	0.995	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.005	0.995	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.005	0.995	0.000
T42.2 Succinimides and oxazolidinediones	0.005	0.995	0.000
N81.4 Uterovaginal prolapse, unspecified	0.005	0.995	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.005	0.995	0.000
R29.1 Meningismus	0.000	0.995	0.005
T42.3 Barbiturates	0.005	0.995	0.000
L90.0 Lichen sclerosus et atrophicus	0.000	0.995	0.005
F20.8 Other schizophrenia	0.005	0.995	0.000
T42.4 Benzodiazepines	0.005	0.995	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.996	0.000
C15.5 Lower third of oesophagus	0.000	0.996	0.004
M23.51 Chronic instability of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.004	0.996	0.000
R29.4 Clicking hip	0.000	0.996	0.004
R29.3 Abnormal posture	0.000	0.996	0.004
D23.6 Skin of upper limb, including shoulder	0.004	0.996	0.000
F81.9 Developmental disorder of scholastic skills, unspecified	0.000	0.996	0.004
K43.9 Ventral hernia without obstruction or gangrene	0.000	0.996	0.004
Z71.3 Dietary counselling and surveillance	0.000	0.996	0.004
R29.0 Tetany	0.000	0.996	0.004
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.004	0.996	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
K43 Ventral hernia	0.000	0.996	0.004
H04.5 Stenosis and insufficiency of lachrymal passages	0.000	0.996	0.004
F20.6 Simple schizophrenia	0.004	0.996	0.000
F20.4 Postschizophrenic depression	0.004	0.996	0.000
F20.3 Undifferentiated schizophrenia	0.004	0.996	0.000
F20.1 Hebephrenic schizophrenia	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
O80.0 Spontaneous vertex delivery	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
R29.2 Abnormal reflex	0.000	0.996	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
F20.2 Catatonic schizophrenia	0.004	0.996	0.000
K81.1 Chronic cholecystitis	0.000	0.996	0.004
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
K43.1 Ventral hernia with gangrene	0.000	0.996	0.004
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.996	0.000
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.000	0.996	0.004
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.003	0.996	0.000
K81 Cholecystitis	0.000	0.997	0.003
D47.1 Chronic myeloproliferative disease	0.003	0.997	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.003	0.997	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.997	0.003
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.003	0.997	0.000
K43.7 Other and unspecified ventral hernia with gangrene	0.000	0.997	0.003
K43.6 Other and unspecified ventral hernia with obstruction, without gangrene	0.000	0.997	0.003
K43.5 Parastomal hernia without obstruction or gangrene	0.000	0.997	0.003
K43.4 Parastomal hernia with gangrene	0.000	0.997	0.003
K43.3 Parastomal hernia with obstruction, without gangrene	0.000	0.997	0.003
K43.2 Incisional hernia without obstruction or gangrene	0.000	0.997	0.003
C18.2 Ascending colon	0.000	0.997	0.003
J91 Pleural effusion in conditions classified elsewhere	0.000	0.997	0.003
Q50.4 Embryonic cyst of Fallopian tube	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
Z49 Care involving dialysis	0.000	0.997	0.003
H90.2 Conductive hearing loss, unspecified	0.003	0.997	0.000
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.000	0.997	0.003
R87.6 Abnormal cytological findings	0.003	0.997	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.003	0.997	0.000
S79.9 Unspecified injury of hip and thigh	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
T40.1 Heroin	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
F81 Specific developmental disorders of scholastic skills	0.000	0.997	0.003
T40.5 Cocaine	0.003	0.997	0.000
D69.5 Secondary thrombocytopenia	0.000	0.997	0.003
T90.2 Sequelae of fracture of skull and facial bones	0.003	0.997	0.000
L30 Other dermatitis	0.000	0.997	0.003
K81.8 Other cholecystitis	0.000	0.997	0.003
T40.2 Other opioids	0.003	0.997	0.000
L29.0 Pruritus ani	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.997	0.000
Z49.1 Extracorporeal dialysis	0.000	0.997	0.003
K31.7 Polyp of stomach and duodenum	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.997	0.000
C15.9 Oesophagus, unspecified	0.000	0.998	0.002
Z49.2 Other dialysis	0.000	0.998	0.002
C22.9 Liver, unspecified	0.002	0.998	0.000
R87 Abnormal findings in specimens from female genital organs	0.002	0.998	0.000
D23.2 Skin of ear and external auricular canal	0.002	0.998	0.000
F81.8 Other developmental disorders of scholastic skills	0.000	0.998	0.002
F81.3 Mixed disorder of scholastic skills	0.000	0.998	0.002
F81.2 Specific disorder of arithmetical skills	0.000	0.998	0.002
F81.1 Specific spelling disorder	0.000	0.998	0.002
F81.0 Specific reading disorder	0.000	0.998	0.002
K74.0 Hepatic fibrosis	0.000	0.998	0.002
A87.9 Viral meningitis, unspecified	0.000	0.998	0.002
D69 Purpura and other haemorrhagic conditions	0.000	0.998	0.002
L29 Pruritus	0.000	0.998	0.002
L30.3 Infective dermatitis	0.000	0.998	0.002
D69.1 Qualitative platelet defects	0.000	0.998	0.002
K55.0 Acute vascular disorders of intestine	0.000	0.998	0.002
M24.54 Contracture of joint (Hand)	0.002	0.998	0.000
G45.4 Transient global amnesia	0.002	0.998	0.000
R87.7 Abnormal histological findings	0.002	0.998	0.000
G91.9 Hydrocephalus, unspecified	0.000	0.998	0.002
L30.5 Pityriasis alba	0.000	0.998	0.002
L30.2 Cutaneous autosensitisation	0.000	0.998	0.002
F80.1 Expressive language disorder	0.000	0.998	0.002
C15 Malignant neoplasm of oesophagus	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
C22.0 Liver cell carcinoma	0.002	0.998	0.000
L30.0 Nummular dermatitis	0.000	0.998	0.002
L30.1 Dyshidrosis [pompholyx]	0.000	0.998	0.002
D69.9 Haemorrhagic condition, unspecified	0.000	0.998	0.002
R87.5 Abnormal microbiological findings	0.002	0.998	0.000
M24.57 Contracture of joint (Ankle and foot)	0.002	0.998	0.000
R87.9 Unspecified abnormal finding	0.002	0.998	0.000
T90.9 Sequelae of unspecified injury of head	0.002	0.998	0.000
U80.1 Methicillin resistant agent	0.000	0.998	0.002
I67.8 Other specified cerebrovascular diseases	0.000	0.998	0.002
L29.2 Pruritus vulvae	0.000	0.998	0.002
L20-L30 Dermatitis and eczema	0.000	0.998	0.002
L29.9 Pruritus, unspecified	0.000	0.998	0.002
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
D69.4 Other primary thrombocytopenia	0.000	0.998	0.002
K86.9 Disease of pancreas, unspecified	0.000	0.998	0.002
M24.5 Contracture of joint	0.002	0.998	0.000
R87.8 Other abnormal findings	0.002	0.998	0.000
R87.4 Abnormal immunological findings	0.002	0.998	0.000
R87.3 Abnormal level of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R87.2 Abnormal level of other drugs, medicaments and biological substances	0.002	0.998	0.000
R87.1 Abnormal level of hormones	0.002	0.998	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.000	0.998	0.002
R87.0 Abnormal level of enzymes	0.002	0.998	0.000
L25 Unspecified contact dermatitis	0.000	0.998	0.002
T90 Sequelae of injuries of head	0.002	0.998	0.000
L29.1 Pruritus scroti	0.000	0.998	0.002
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.002	0.998	0.000
C22.1 Intrahepatic bile duct carcinoma	0.002	0.998	0.000
L25.9 Unspecified contact dermatitis, unspecified cause	0.000	0.998	0.002
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
F80 Specific developmental disorders of speech and language	0.000	0.998	0.002
J15.1 Pneumonia due to Pseudomonas	0.002	0.998	0.000
M79.8 Other specified soft tissue disorders	0.000	0.998	0.002
C15.8 Overlapping lesion of oesophagus	0.000	0.998	0.002
C15.2 Abdominal part of oesophagus	0.000	0.998	0.002
M70.46 Prepatellar bursitis-Lower Leg	0.002	0.998	0.000
D69.8 Other specified haemorrhagic conditions	0.000	0.998	0.002
L27.2 Dermatitis due to ingested food	0.000	0.998	0.002
T90.8 Sequelae of other specified injuries of head	0.002	0.998	0.000
K74.5 Biliary cirrhosis, unspecified	0.000	0.998	0.002
Z71.9 Counselling, unspecified	0.000	0.998	0.002
C15.1 Thoracic part of oesophagus	0.000	0.998	0.002
L30.4 Erythema intertrigo	0.000	0.998	0.002
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.002	0.998	0.000
H00 Hordeolum and chalazion	0.002	0.998	0.000
M24.51 Contracture of joint (Shoulder region)	0.002	0.998	0.000
D69.0 Allergic purpura	0.000	0.998	0.002
H57.9 Disorder of eye and adnexa, unspecified	0.000	0.998	0.002
L23 Allergic contact dermatitis	0.000	0.998	0.002
M24.56 Contracture of joint (Lower leg)	0.002	0.998	0.000
C15.3 Upper third of oesophagus	0.000	0.998	0.002
L23.1 Allergic contact dermatitis due to adhesives	0.000	0.998	0.002
L29.3 Anogenital pruritus, unspecified	0.000	0.998	0.002
M51.8 Other specified intervertebral disk disorders	0.002	0.998	0.000
M79.83 Other specified soft tissue disorders (Forearm)	0.000	0.998	0.002
C77.1 Intrathoracic lymph nodes	0.000	0.998	0.002
M24.55 Contracture of joint (Pelvic region and thigh)	0.002	0.998	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.001	0.998	0.000
L24 Irritant contact dermatitis	0.000	0.998	0.002
L22 Diaper [napkin] dermatitis	0.000	0.998	0.002
M87.97 Osteonecrosis, unspecified (Ankle and foot)	0.002	0.998	0.000
M23.5 Chronic instability of knee	0.002	0.998	0.000
T90.4 Sequelae of injury of eye and orbit	0.002	0.998	0.000
L27 Dermatitis due to substances taken internally	0.000	0.998	0.001
X62.9 Unspecified place	0.002	0.998	0.000
L28 Lichen simplex chronicus and prurigo	0.000	0.998	0.002
M24.59 Contracture of joint (Site unspecified)	0.002	0.998	0.000
M24.58 Contracture of joint (Other)	0.002	0.998	0.000
M24.53 Contracture of joint (Forearm)	0.002	0.998	0.000
M24.52 Contracture of joint (Upper arm)	0.002	0.998	0.000
M24.50 Contracture of joint (Multiple sites)	0.002	0.998	0.000
D14.0 Middle ear, nasal cavity and accessory sinuses	0.000	0.998	0.002
F80-F89 Disorders of psychological development	0.000	0.998	0.002
L20 Atopic dermatitis	0.000	0.998	0.002
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.002	0.998	0.000
C22.7 Other specified carcinomas of liver	0.002	0.998	0.000
C22.4 Other sarcomas of liver	0.002	0.998	0.000
C22.3 Angiosarcoma of liver	0.002	0.998	0.000
C22.2 Hepatoblastoma	0.002	0.998	0.000
D22.6 Melanocytic naevi of upper limb, including shoulder	0.002	0.998	0.000
H44.5 Degenerated conditions of globe	0.002	0.998	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.000	0.998	0.002
L25.8 Unspecified contact dermatitis due to other agents	0.000	0.998	0.001
L25.5 Unspecified contact dermatitis due to plants, except food	0.000	0.998	0.001
L25.4 Unspecified contact dermatitis due to food in contact with the skin	0.000	0.998	0.001
L25.3 Unspecified contact dermatitis due to other chemical products	0.000	0.998	0.001
L25.2 Unspecified contact dermatitis due to dyes	0.000	0.998	0.001
L25.1 Unspecified contact dermatitis due to drugs in contact with the skin	0.000	0.998	0.001
L25.0 Unspecified contact dermatitis due to cosmetics	0.000	0.998	0.001
L26 Exfoliative dermatitis	0.000	0.998	0.002
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.000	0.998	0.002
M65.14 Other infective (teno)synovitis (Hand)	0.000	0.998	0.002
C15.4 Middle third of oesophagus	0.000	0.998	0.002
C15.0 Cervical part of oesophagus	0.000	0.998	0.001
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.000	0.998	0.002
T90.3 Sequelae of injury of cranial nerves	0.002	0.998	0.000
F80.9 Developmental disorder of speech and language, unspecified	0.000	0.998	0.001
F80.8 Other developmental disorders of speech and language	0.000	0.998	0.001
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.000	0.998	0.001
F80.0 Specific speech articulation disorder	0.000	0.998	0.001
G31.2 Degeneration of nervous system due to alcohol	0.000	0.998	0.002
H44.1 Other endophthalmitis	0.002	0.998	0.000
D69.2 Other nonthrombocytopenic purpura	0.000	0.998	0.001
L23.5 Allergic contact dermatitis due to other chemical products	0.000	0.998	0.001
M87.9 Osteonecrosis, unspecified	0.002	0.998	0.000
T90.5 Sequelae of intracranial injury	0.002	0.998	0.000
Z71.4 Alcohol abuse counselling and surveillance	0.000	0.998	0.002
L21 Seborrhoeic dermatitis	0.000	0.998	0.002
M24.28 Disorder of ligament (Other)	0.002	0.998	0.000
D75.8 Other specified diseases of blood and blood-forming organs	0.000	0.998	0.002
I87.8 Other specified disorders of veins	0.002	0.998	0.000
L29.8 Other pruritus	0.000	0.998	0.001
M23.50 Chronic instability of knee (Multiple sites)	0.001	0.998	0.000
I07.1 Tricuspid insufficiency	0.002	0.998	0.000
T90.0 Sequelae of superficial injury of head	0.001	0.998	0.000
V89.9 Person injured in unspecified vehicle accident	0.000	0.998	0.002
Z50.5 Speech therapy	0.000	0.998	0.002
M79.88 Other specified soft tissue disorders (Other)	0.000	0.998	0.001
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.001	0.998	0.000
Q50.3 Other congenital malformations of ovary	0.001	0.998	0.000
Q50.2 Congenital torsion of ovary	0.001	0.998	0.000
Q50.1 Developmental ovarian cyst	0.001	0.998	0.000
Q50.0 Congenital absence of ovary	0.001	0.998	0.000
M62.81 Other specified disorders of muscle (Shoulder region)	0.000	0.998	0.002
K65.9 Peritonitis, unspecified	0.000	0.998	0.002
L23.7 Allergic contact dermatitis due to plants, except food	0.000	0.998	0.001
L23.6 Allergic contact dermatitis due to food in contact with the skin	0.000	0.998	0.001
L23.4 Allergic contact dermatitis due to dyes	0.000	0.998	0.001
L23.2 Allergic contact dermatitis due to cosmetics	0.000	0.998	0.001
F80.2 Receptive language disorder	0.000	0.998	0.001
L23.3 Allergic contact dermatitis due to drugs in contact with the skin	0.000	0.998	0.001
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations